Epsilon Healthcare Limited

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 06:37:33 2023-12-17 pm EST			5-day change	1st Jan Change
0.024 ^AUD	-.--%		-.--%	-.--%

2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI
2023	Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	CI

Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023

November 20, 2023 at 05:27 pm EST

Epsilon Healthcare Limited announces that effective from 22 November 2023 the Company's Registered Office and Principal Place of business will be changed as follows: New address and contact details: 20 Grose Street North Parramatta NSW 2151. Telephone: 02 8839 3000. Fax: 02 8839 3055.

Latest news about Epsilon Healthcare Limited

Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	Dec. 19	CI
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	Dec. 19	CI
Epsilon Healthcare Appoints Joint and Several Administrators	Dec. 18	MT
Epsilon Healthcare Limited Provides Information to Shareholders	Dec. 14	CI
Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd	Nov. 30	CI
Epsilon Healthcare Limited Announces Board Appointments	Nov. 30	CI
Epsilon Healthcare Provides Information to Shareholders	Nov. 22	CI
Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer	Nov. 21	CI
Epsilon Healthcare Issues Notice of Extraordinary General Meeting	Nov. 20	CI
Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023	Nov. 20	CI
Epsilon Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Epsilon Healthcare Rebrands Manufacturing, Telehealth Businesses	23-08-03	MT
Epsilon Healthcare Appoints CEO	23-05-18	MT
Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023	23-05-18	CI
Healthcare, IT Rally Ends Australian Shares' Three-Day Losing Streak	23-05-12	MT
Epsilon Healthcare Jumps 25% After Subsidiary Renews Medicinal Cannabis Permit	23-05-12	MT
Epsilon Healthcare Limited Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Epsilon Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Epsilon Healthcare Limited Announces Executive Changes	22-12-23	CI
Epsilon Healthcare Limited Announces Company Secretary Changes	22-11-30	CI
Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer	22-11-30	CI
Epsilon Healthcare Limited Announces Change of Registered Office and Principal Place of Business	22-11-30	CI
Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director	22-11-03	CI
Epsilon Healthcare Limited Announces Board Changes	22-10-31	CI
Epsilon Healthcare Limited Announces Appointment of Josh Cui as Director	22-10-30	CI

Chart Epsilon Healthcare Limited

Duration

Period

More charts

Company Profile

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EPSILON HEALTHCARE LIMITED	-.--%	4.77M
ELI LILLY AND COMPANY	+26.08%	662B
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
PFIZER, INC.	-3.40%	157B